The use of oxyphenbutazone ('Tanderil') in acute pelvic inflammatory disease.
D005260:Female; D005500:Follow-Up Studies; D006069:Gonorrhea / Q000150:complications; D006801:Humans; D007630:Kenya; D007902:Length of Stay; D008297:Male; D009344:Neisseria gonorrhoeae / Q000302:isolation & purification; D010113:Oxyphenbutazone / Q000008:administration & dosage / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy* / Q000209:etiology; D010919:Placebos; D013752:Tetracycline / Q000008:administration & dosage / Q000627:therapeutic use; D014521:Urethra / Q000382:microbiology; D002577:Uterine Cervical Diseases / Q000382:microbiology
D010919:Placebos; D013752:Tetracycline; D010113:Oxyphenbutazone